Increasing Orthopedic Disease & Musculoskeletal Disease Burden Globally Is Expected To Drive Orthobiologics Market Till 2025: Grand View Research, Inc.
The
global orthobiologics market is expected to reach USD
10.2 billion by 2025, according to a new study by Grand View Research, Inc. The
orthobiologics market is predominantly driven by the increasing orthopedic
disease and musculoskeletal disease burden globally. Moreover, emerging
technological innovations in biomaterials, used in the production of
orthobiologics are presumed to accelerate the market demand over the forecast
period. These predominantly include modifications in graft designs, advent of recombinant
biologic agents, stem cell therapy and cultured tissue scaffolds.
These
advancements are accompanied with the benefits such as enhanced
biocompatibility, reduced surgical time and smaller incisions. Furthermore,
these novel solutions are presumed to efficiently reduce the recurrence of
post-operative complications, which in turn is expected to boost the
orthobiologics market during the forecast period.
Browse full research report on Orthobiologics
Market: http://www.grandviewresearch.com/industry-analysis/orthobiological-products-market
Further key findings from the study suggest:
- In
2015, viscosupplementation accounted for the largest share in the product
segment owing to being a cost efficient therapeutic alternative for symptomatic
management of osteoarthritis
- Spinal
fusion held the largest share in the application segment in 2015, owing to
presence of third party insurers and reimbursement structure for fusion
enhancement products thus triggering growth
- In
2015, North America accounted for the dominant share owing to consistent
efforts of industry players in promoting awareness pertinent to the
orthobiological products resulting in significant rise in adoption rate
- Asia
Pacific is anticipated to exhibit an exponential CAGR as a consequence of
significant surge in healthcare spending and awareness levels with respect
to the availability of orthobiologics
- The
prominent players are consistently indulging into extensive strategies to
gain competitive position including regional expansion and mergers &
acquisitions to capture a greater market share
- For
instance, in November 2015, Bioventus acquired BioStructures, a
bioabsorbable bone graft developer. This acquisition was carried out to
expand orthobiologics product portfolio and grafting solutions in order to
expand their market share
Access
Press Release By Grand View Research: http://www.grandviewresearch.com/press-release/global-orthobiological-market
About
Grand View Research, Inc:
Grand View Research, Inc. is a U.S. based market
research and consulting company, registered in the State of California and
headquartered in San Francisco. The company provides syndicated research
reports, customized research reports, and consulting services. To help clients
make informed business decisions, the company offers market intelligence
studies ensuring relevant and fact-based research across a range of industries
including technology, chemicals, materials, healthcare and energy.
Comments
Post a Comment